Synthesis, spectral and crystal studies of 2-(4,6-diamino pyrimidin-2-ylthio)-N-m/p-tolyl/3,4-dimethylacetamides

Ajay Kumar Timiri, Vishnu Nayak Badavath, Barij Nayan Sinha, Venkatesan Jayaprakash, Subasri Selvarasu, Vishwanathan Vijayan, Velmurugan Devadasan

Abstract


Heterocyclic molecules always have a demand in medicinal chemistry research. Pyrimidines are interesting and important scaffold for study of biological importance as many essential biomolecules have pyrimidine structure embedded. Pyrimidines are also reported as inhibitors for biological activities like antibacterial, antifungal, anticancer, antiviral, a few to mention. Here we present the synthesis and X-ray crystal structure of the 2-(4,6-diaminopyrimidin-2-ylthio)-N-phenylacetamide derivatives. X-ray diffraction intensity data were collected at room temperature (293K) on a Bruker axs SMART APEXII single crystal X-ray diffractometer equipped with graphite monochromatic Mo K? (?=0.71073 radiation and CCD detector. The compound IIIa crystallizes in the monoclinic P21/c space group with four molecules in the unit cell (a=22.857 b=7.4305 c=8.3686 ?=90, ?=93.454, ?=90 and Z=4). The compound IIIb crystallizes in the orthorhombic Pbca space group with eight molecules in the unit cell (a=18.2022 b=7.5132 c=20.0233 ?=90, ?=90, ?=90 and Z=8). The compound IIIc crystallizes in the monoclinic P21/c space group with four molecules in the unit cell (a=24.254 b=7.3424 c=8.4257 ?=90, ?=93.282, ?=90 and Z=4).

Keywords


Heterocycles; Diaminopyrimidine; Crystal structure; Acetamide; Antiviral

Full Text:

PDF

References


Quin LD, Tyrell JA. Fundamentals of Heterocyclic Chemistry: Importance in Nature and in the Synthesis of Pharmaceuticals: John Wiley & Sons; 2010.

Kappe CO. Biologically active dihydropyrimidones of the Biginelli-typea literature survey. Eur J Med Chem. 2000;35(12):1043-52. http://dx.doi.org/10.1016/S0223-5234(00)01189-2

Waller CW, Hutchings BL, Mowat JH, Stokstad E, Boothe JH, Angier RB, et al. Synthesis of pteroylglutamic acid (liver L. casei factor) and pteroic acid. I. J Am Chem Soc. 1948;70(1):19-22.

http://dx.doi.org/10.1021/ja01181a006

Chakravarty P, Suryanarayanan R. Characterization and structure analysis of thiamine hydrochloride methanol solvate. Cryst Growth Des. 2010;10(10):4414-20. http://dx.doi.org/10.1021/cg100522f

Ozeki K, Sakabe N, Tanaka J. The crystal structure of thymine. Acta Crystallogr B. 1969;25(6):1038-45.

http://dx.doi.org/10.1107/S0567740869003505

Parry GS. The crystal structure of uracil. Acta Crystallogr. 1954;7(4):313-20.

http://dx.doi.org/10.1107/S0365110X54000904

Barker D, Marsh R. The crystal structure of cytosine. Acta Crystallogr. 1964;17(12):1581-7.

http://dx.doi.org/10.1107/S0365110X64003899

Agarwal A, Srivastava K, Puri S, Chauhan P. Synthesis of 2, 4, 6-trisubstituted pyrimidines as antimalarial agents. Bioorg Med Chem. 2005;13(15):4645-50. http://dx.doi.org/10.1016/j.bmc.2005.04.061

Zhang N, Ayral-Kaloustian S, Nguyen T, Afragola J, Hernandez R, Lucas J, et al. Synthesis and SAR of [1, 2, 4] triazolo [1, 5-a] pyrimidines, a class of anticancer agents with a unique mechanism of tubulin inhibition. J Med Chem. 2007;50(2):319-27. http://dx.doi.org/10.1021/jm060717i

Lukasik PM, Elabar S, Lam F, Shao H, Liu X, Abbas AY, et al. Synthesis and biological evaluation of imidazo [4, 5- b] pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agents. Eur J Med Chem. 2012;57:311-22.

http://dx.doi.org/10.1016/j.ejmech.2012.09.034

Kumar R, Nair RR, Dhiman SS, Sharma J, Prakash O. Organoiodine (III)-mediated synthesis of 3-aryl/heteroaryl-5, 7-dimethyl-1, 2, 4-triazolo [4, 3-c] pyrimidines as antibacterial agents. Eur J Med Chem. 2009;44(5):2260-4.

http://dx.doi.org/10.1016/j.ejmech.2008.06.004

Guerry P, Jolidon S, Masciadri R, Stalder H, Then R, inventors; WO 9616046 A2 19960530, assignee. Novel benzyl pyrimidines1996.

Devi N, Khuman C, Singh R, Singh L. Synthesis of pyrimido [4, 5-d] pyrimidines as antifungal agents. Indian J Heterocyc Chem. 1998;7(3):193-6.

Hol A, Votruba I, Masojdkov M, Andrei G, Snoeck R, Naesens L, et al. 6-[2-(Phosphonomethoxy) alkoxy] pyrimidines with antiviral activity. J Med Chem. 2002;45(9):1918-29. http://dx.doi.org/10.1021/jm011095y

Qiu Y, Ptak R, Breitenbach J, Lin J, Cheng Y, Kern E, et al. (Z)-and (E)-2-(hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents. Antiviral Chem Chemother. 1998;9(4):341-52.

http://dx.doi.org/10.1177/095632029800900406

De Clercq E. Therapeutic potential of phosphonylmethoxyalkylpurines and-pyrimidines as antiviral agents. Drugs Under Exp Clin Res. 1989;16(7):319-26.

Sharma M, Chaturvedi V, Manju Y, Bhatnagar S, Srivastava K, Puri S, et al. Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents. Eur J Med Chem. 2009;44(5):2081-91.

http://dx.doi.org/10.1016/j.ejmech.2008.10.011

Patel R, Desai P, Desai K, Chikhalia K. Synthesis of pyrimidine based thiazolidinones and azetidinones: antimicrobial and antitubercular agents. Ind J Chem B. 2006;45(3):773.

http://dx.doi.org/10.1002/chin.200628143

Rollo I. Drugs used in the chemotherapy of helminthiasis1980. Available from: http://www.popline.org/node/468309

Bekhit AA, Fahmy HT, Rostom SA, Baraka AM. Design and synthesis of some substituted 1H-pyrazolyl-thiazolo [4, 5-d] pyrimidines as anti-inflammatoryantimicrobial Agents. Eur J of Med Chem. 2003;38(1):27-36.

http://dx.doi.org/10.1016/S0223-5234(02)00009-0

Kimura T, Ohno M, Ikeda M, Watanabe K, Kondo S, Ho I, et al., editors. Antianxiety effects of N3-phenacyluridine in mice. Nucl Acid Symp Ser; 1998: [London]: Information Retrieval Ltd., c1979-c2000.

Quintela J, Peinador C, Botana L, Estvez M, Riguera R. Synthesis and antihistaminic activity of 2-guanadino-3-cyanopyridines and pyrido [2, 3-d]-pyrimidines. Bioorg Med Chem. 1997;5(8):1543-53.

http://dx.doi.org/10.1016/S0968-0896(97)00108-9

Shishoo CJ, Shirsath VS, Rathod IS, Yande VD. Design, synthesis and antihistaminic (H1) activity of some condensed 3-aminopyrimidin-4 (3H)-ones. Eur J Med Chem. 2000;35(3):351-8. http://dx.doi.org/10.1016/S0223-5234(00)00128-8

Bennett LR, Blankley CJ, Fleming RW, Smith RD, Tessman DK. Antihypertensive activity of 6-arylpyrido [2, 3-d] pyrimidin-7-amine derivatives. J Med Chem. 1981;24(4):382-9. http://dx.doi.org/10.1021/jm00136a006

Kelton J, Hirsh J, editors. Bleeding associated with antithrombotic therapy. Semin Hematol; 1980.

Marchetti M, Puddu P, Caldarera C. Metabolic aspects oforotic acid fatty liver'. Nucleotide control mechanisms of lipid metabolism. Biochem J. 1964;92(1):46.

Nowak K, Sury?o P. Leki przeciwtr?dowe. Wiadomo?ci Chem. 2006:257-78.

Periti P. Brodimoprim, a new bacterial dihydrofolate reductase inhibitor: a minireview. J Chemother. 1995;7(3):221-3. http://dx.doi.org/10.1179/joc.1995.7.3.221

Reuter M, Loenicker E, Reuter H. [Antibacterial treatment of urinary tract infections with co-tetroxazin (sterinor)]. Fortschritte der Medizin. 1981;99(17):654-8.

van Oosterom R, Hartman E, Hartman E. Pipemidic acid, a new treatment for recurrent urinary tract infection in small animals. Vet Quart. 1986;8(1):2-5. http://dx.doi.org/10.1080/01652176.1986.9694011

Sweet R, Wasterlain C, McDowell F. Piribedil, a dopamine agonist, in Parkinson's disease. Clin Pharmacol Ther. 1974;16(6):1077-82.

Bruker Inc A. APEX2 (Version 1.08), SAINT (Version 7.03), SADABS (Version 2.11), SHELXTL (Version 6.12). Bruker Advanced X-ray Solutions, Madison. 2004.

Sheldrick G. A short history of SHELX. Acta Crystallogr A. 2008;64(1):112-22.

http://dx.doi.org/10.1107/S0108767307043930

Nardelli M. PARST95 - an update to PARST: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analyses. J Appl Crystallogr. 1995;28(5):659.

http://dx.doi.org/10.1107/S0021889895007138

Farrugia L. WinGX and ORTEP for Windows: an update. J Appl Crystallogr. 2012;45(4):849-54.

http://dx.doi.org/10.1107/S0021889812029111

Spek A. Structure validation in chemical crystallography. Acta Crystallogr D. 2009;65(2):148-55. http://dx.doi.org/10.1107/S090744490804362X




DOI: http://dx.doi.org/10.14805/fda.201511.7-14

Refbacks

  • There are currently no refbacks.


VENSEL PUBLICATIONS@2017

20, Keelavaithianathapuram, 4th Street, Madurai-625 018 (TN), India